Digital Sponsored How to deal with fragmented data - A $12.9 million challenge In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital Adopting AI platforms: A structured framework for thoughtful... The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.
Digital Mixed reactions among HCPs as lecanemab and donanemab secure... Last month, the FDA granted approval to Eli Lilly’s donanemab - or Kisunla - for the treatment of Alzheimer’s disease.
Digital Tech & Trials: What’s all this about AI, then? Welcome to Tech & Trials – a guided tour to the world of AI and clinical trials.
Digital Driving growth with connected health Connected health stands at the intersection of healthcare and technology, where innovation is reshaping patient care.
Digital The fall and rise of digital therapeutics A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that
Oncology ESMO26: Taiho Oncology on improving the lives of patients wi... Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.